• Successful launch of four next-generation products
• Gross margins above 50% and net margins of 41.6%
• Net operating margin more than double previous period
• Cash position of $9.37m at 31 December 2024

BirdDog Technology Ltd (ASX:BDT) announced its H1 FY25 results, showcasing the successful launch of four out of 12 planned next-generation products, with gross margins above 50% and net margins of 41.6% - a substantial improvement over the previous corresponding period. The company's net operating margin more than doubled to 36.1%, and it maintained a strong cash position of $9.37m as of 31 December 2024. The H1 FY25 results reflect launch costs for the new products, the impact of a camera trade-in program, and lower revenue from the UK and European markets due to challenging macroeconomic conditions. However, the company is rebuilding market confidence following a legal settlement in July 2024. BirdDog is focused on broadening its market penetration, driving revenue growth through its full product range, and accelerating the commercialization of its Remedi technology for proven medical applications.

BirdDog is focused on broadening its market penetration and driving revenue growth through its full product range, including the launch of eight more next-generation products in H2 2025. The company is also accelerating the commercialization of its Remedi technology for proven medical applications, with a laser-focused approach on the US market.